![RD:IR volunteering](/sites/default/files/styles/square_card_l/public/media/images/media-1476.jpg.webp?itok=r80kDHLc)
A spot of painting at Lymphoma Action HQ
Volunteers from RD:IR give Lymphoma Action offices a face lift.
Read the latest news and views from Lymphoma Action.
Use the drop down filter to find the most relevant news for you.
Volunteers from RD:IR give Lymphoma Action offices a face lift.
Duvelisib reports promising efficacy in people with low-grade non-Hodgkin lymphomas who have not responded to previous treatment.
Teenage and Young Adult Cancer Study published.
NICE approves brentuximab vedotin for advanced primary cutaneous anaplastic large cell lymphoma, mycosis fungoides and Sézary syndrome.
The British Society of Haematology has released new guidelines on the diagnosis and treatment of PMBCL.
Lymphoma Action's Stephen Scowcroft comments on rare lymphoma that developed after heart transplant.
Tisagenlecleucel (Kymriah®) not available for use on the NHS in Scotland
Tom has lymphoma storybook recently published.
Second person in remission from HIV after a donor stem cell transplant for blood cancer.